Solventum Corp. (SOLV)
NYSE · Healthcare · Medical Instruments & Supplies
Solventum Corp. is a Healthcare company with a market capitalization of $13.77B and a trailing P/E ratio of 9.7.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 5, 2026 | $1.48 | $1.34 | +10.4% |
| Q4 2025 | February 26, 2026 | $1.57 | $1.75 | -10.3% |
| Q3 2025 | November 6, 2025 | $1.50 | $1.77 | -15.3% |
| Q2 2025 | August 7, 2025 | $1.69 | $1.68 | +0.6% |
| Q1 2025 | May 8, 2025 | $1.34 | $1.57 | -14.6% |
| Q4 2024 | February 27, 2025 | $1.41 | $1.50 | -6.0% |
Other Medical Instruments & Supplies Stocks
Frequently Asked Questions
What is Solventum Corp.'s market cap?
As of June 29, 2026, Solventum Corp. (SOLV) has a market capitalization of $13.77B.
What is Solventum Corp.'s P/E ratio?
Solventum Corp. trades at a trailing price-to-earnings (P/E) ratio of 9.7. Its forward P/E is 12.1.
Does Solventum Corp. pay a dividend?
Solventum Corp. does not currently pay a dividend.
What sector is SOLV in?
Solventum Corp. is in the Healthcare sector, specifically the Medical Instruments & Supplies industry.
What was Solventum Corp.'s revenue?
In its latest reported fiscal year (ending December 31, 2025), Solventum Corp. reported revenue of $8.32B and net income of $1.56B.
Ask your own questions about SOLV
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.